These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 19363377)
21. Process-of-care measures as predictors of client outcome among a methamphetamine-dependent sample at 12- and 36-month follow-ups. Rawson RA; Gonzales R; Greenwell L; Chalk M J Psychoactive Drugs; 2012; 44(4):342-9. PubMed ID: 23210383 [TBL] [Abstract][Full Text] [Related]
22. Course of Psychiatric Symptoms and Abstinence among Methamphetamine-Dependent Persons in Sober Living Recovery Homes. Polcin DL; Witbrodt J; Korcha R; Gupta S; Mericle AA J Psychoactive Drugs; 2016; 48(3):173-80. PubMed ID: 27184803 [TBL] [Abstract][Full Text] [Related]
23. Predictors of persistent psychotic symptoms in persons with methamphetamine abuse receiving psychiatric treatment. Lecomte T; Mueser KT; MacEwan W; Thornton AE; Buchanan T; Bouchard V; Goldner E; Brink J; Lang D; Kang S; Barr AM; Honer WG J Nerv Ment Dis; 2013 Dec; 201(12):1085-9. PubMed ID: 24284645 [TBL] [Abstract][Full Text] [Related]
24. Stepping through treatment: reflections on an adaptive treatment strategy among methamphetamine users with depression. Kay-Lambkin FJ; Baker AL; McKetin R; Lee N Drug Alcohol Rev; 2010 Sep; 29(5):475-82. PubMed ID: 20887570 [TBL] [Abstract][Full Text] [Related]
25. The influence of depression on treatment for methamphetamine use. Kay-Lambkin FJ; Baker AL; Lee NM; Jenner L; Lewin TJ Med J Aust; 2011 Aug; 195(3):S38-43. PubMed ID: 21806517 [TBL] [Abstract][Full Text] [Related]
26. Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men. Peck JA; Reback CJ; Yang X; Rotheram-Fuller E; Shoptaw S J Urban Health; 2005 Mar; 82(1 Suppl 1):i100-8. PubMed ID: 15738315 [TBL] [Abstract][Full Text] [Related]
27. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program. Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217 [TBL] [Abstract][Full Text] [Related]
28. The relationship between methamphetamine and alcohol use in a community sample of methamphetamine users. Bujarski S; Roche DJ; Lunny K; Moallem NR; Courtney KE; Allen V; Hartwell E; Leventhal A; Rohrbaugh T; Ray LA Drug Alcohol Depend; 2014 Sep; 142():127-32. PubMed ID: 24975477 [TBL] [Abstract][Full Text] [Related]
29. Methamphetamine withdrawal and the restoration of cognitive functions - a study over a course of 6 months abstinence. Proebstl L; Krause D; Kamp F; Hager L; Manz K; Schacht-Jablonowsky M; Straif M; Riebschläger M; Neumann S; Schreiber A; Soyka M; Koller G Psychiatry Res; 2019 Nov; 281():112599. PubMed ID: 31629302 [TBL] [Abstract][Full Text] [Related]
30. Cognitive impairment in methamphetamine users with recent psychosis: A cross-sectional study in Thailand. Srisurapanont M; Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Jantamo P Drug Alcohol Depend; 2020 May; 210():107961. PubMed ID: 32302795 [TBL] [Abstract][Full Text] [Related]
31. Psychotic symptoms in methamphetamine psychotic in-patients. Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449 [TBL] [Abstract][Full Text] [Related]
32. Parallel Effects of Methamphetamine on Anxiety and CCL3 in Humans and a Genetic Mouse Model of High Methamphetamine Intake. Huckans M; Wilhelm CJ; Phillips TJ; Huang ET; Hudson R; Loftis JM Neuropsychobiology; 2017; 75(4):169-177. PubMed ID: 29402784 [TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled trial of citicoline for bipolar and unipolar depression and methamphetamine dependence. Brown ES; Gabrielson B J Affect Disord; 2012 Dec; 143(1-3):257-60. PubMed ID: 22974472 [TBL] [Abstract][Full Text] [Related]
34. Relationship between the duration of methamphetamine use and psychotic symptoms: A two-year prospective cohort study. Ma J; Li XD; Wang TY; Li SX; Meng SQ; Blow FC; Ilgen M; Degenhardt L; Lappin J; Wu P; Shi J; Bao YP; Lu L Drug Alcohol Depend; 2018 Jun; 187():363-369. PubMed ID: 29715654 [TBL] [Abstract][Full Text] [Related]
35. Exercise for methamphetamine dependence: rationale, design, and methodology. Mooney LJ; Cooper C; London ED; Chudzynski J; Dolezal B; Dickerson D; Brecht ML; Peñate J; Rawson RA Contemp Clin Trials; 2014 Jan; 37(1):139-47. PubMed ID: 24291456 [TBL] [Abstract][Full Text] [Related]
37. The impact of neuropsychological functioning and depressed mood on functional complaints in HIV-1 infection and methamphetamine dependence. Sadek JR; Vigil O; Grant I; Heaton RK; J Clin Exp Neuropsychol; 2007 Apr; 29(3):266-76. PubMed ID: 17454347 [TBL] [Abstract][Full Text] [Related]
38. The role of substance use coping in the relation between childhood sexual abuse and depression among methamphetamine users in South Africa. Berg MK; Hobkirk AL; Joska JA; Meade CS Psychol Trauma; 2017 Jul; 9(4):493-499. PubMed ID: 27710005 [TBL] [Abstract][Full Text] [Related]
39. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia. McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414 [TBL] [Abstract][Full Text] [Related]
40. Lifetime Methamphetamine Use Disorder and Reported Sleep Quality in Adults Living with HIV. Sun-Suslow N; Saloner R; Serrano V; Umlauf A; Morgan EE; Ellis RJ; Letendre S; Grant I; Heaton RK AIDS Behav; 2020 Nov; 24(11):3071-3082. PubMed ID: 32274672 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]